Back To Search Instructions
22 protocols meet the specified criteria
Disease Site: Other
Protocol No.TitleStatus
0100000331ANBL00B1: Neuroblastoma Biology StudiesOpen
0500000226Arizona Lymphoid Tissue and Blood Repository (ALTBR)Open
1100000212Skin Cancer Institute Patient Registry and Tissue BankOpen
1100000610A Multicenter Access and Distribution Protocol for Unlicensed Cryopreserved Cord Blood Units (CBUs) for Transplantation in Pediatric and Adult Patients with Hematologic Malignancies and Other Indications (10-CBA)Open
12-1026-04LyP RegistryOpen
1200000148A Multicenter Safety Study of Unlicensed Investigational Cryopreserved Cord Blood Units (CBUs) Manufactured by the National Cord Blood Program (NCBP) and Provided for Unrelated Hematopoietic Stem Cell Transplantation of Pediatric and Adult Patients (6637-01)Open
1200000229Skin Cancer Prevention Program BiorepositoryOpen
1300000696Optimal timing of initial PET/CT surveillance after definitive radiotherapy for head and neck cancersOpen
1300000720Role of concurrent systemic therapy with adjuvant radiation therapy for locally advanced cutaneous squamous cell carcinoma at the University of Arizona Radiation Oncology ClinicOpen
1401183410A Placebo Controlled Double-Blind Study to Evaluate the Efficacy of vismodegib as Chemoprevention of New BCC Development in High Risk SubjectsOpen
1405319847My Life Our Future: A Hemophilia Genotyping Initiative Data and Sample Research RepositoryOpen
1406354010Continuation of a previously approved retrospective review, and a proposal to open a Propsective Registry for patients treated with the Xoft Axxent System device to track safety, efficacy, and cosmetic outcomes in patients with basal and squamous cell cancers.Open
1408448583The Use of In Vivo Confocal Microscopy In Normal and Pathological Cutaneous Lesions Open
1409505107Pilot Study to Evaluate the Signaling Pathway Modulation Demonstrated by Raf, MEK, and Tyrosine Kinase Inhibitors Before and After Acutely Exposing Human Skin to Solar Simulated LightOpen
1410514410Case Registry for Lymphomatoid PapulosisOpen
1412585986Clinical, Morphological, and Histological Effect of Emollient Application in Actinic KeratosesOpen
1501654718A Randomized Phase II Trial for Patients with p16 Positive, Non-Smoking Associated, Locoregionally Advanced Oropharyngeal CancerOpen
1502660379S1316: Prospective Comparative Effectiveness Trial for Malignant Bowel ObstructionOpen
1504821313Pharmacogenetic testing of saliva samples from patients with ≥ 5 exposure days to rFVIIa analogue in the adeptTM2 trialOpen
1506891752Intergroup Randomized Phase II Four Arm Study In Patients With Previously Untreated Mantle Cell Lymphoma Of Therapy With: Arm A = Rituximab+ Bendamustine Followed By Rituximab Consolidation (RB → R); Arm B = Rituximab + Bendamustine + Bortezomib Followed By Rituximab Consolidation (RBV→ R), Arm C = Rituximab + Bendamustine Followed By Lenalidomide + Rituximab Consolidation (RB → LR) or Arm D = Rituximab + Bendamustine + Bortezomib Followed By Lenalidomide + Rituximab Consolidation (RBV → LR) (E1411)Open
21404Behavioral Dose Response StudyOpen